PARP16 and lung carcinoma: Joo‐Young et al. [146] reported that PARP16 plays a key role in cytochrome b5 reductase 3‐induced lung cancer apoptosis by increasing the ADP‐ribosylation of PERK and inositol‐requiring enzyme 1 alpha (IRE1α).